2022
DOI: 10.3389/fmicb.2022.834008
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of Metronidazole-Resistant Giardia intestinalis Lines by Comparative Transcriptomics and Proteomics

Abstract: Metronidazole (MTZ) is a clinically important antimicrobial agent that is active against both bacterial and protozoan organisms. MTZ has been used extensively for more than 60 years and until now resistance has been rare. However, a recent and dramatic increase in the number of MTZ resistant bacteria and protozoa is of great concern since there are few alternative drugs with a similarly broad activity spectrum. To identify key factors and mechanisms underlying MTZ resistance, we utilized the protozoan parasite… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 85 publications
1
12
0
Order By: Relevance
“…The following PRIDE projects were used: PXD017597, PXD004398, PXD000452, PXD002398, PXD007183 and PXD022565. Additionally, two recent proteomic studies that use the updated version of the Giardia genome [67,68]. The results showed evidence of translation for only a subset of VSP proteins with unique peptides (29/136), which is in agreement with the results of the transcriptional analysis.…”
Section: Transcriptomic and Proteomic Analyzessupporting
confidence: 78%
“…The following PRIDE projects were used: PXD017597, PXD004398, PXD000452, PXD002398, PXD007183 and PXD022565. Additionally, two recent proteomic studies that use the updated version of the Giardia genome [67,68]. The results showed evidence of translation for only a subset of VSP proteins with unique peptides (29/136), which is in agreement with the results of the transcriptional analysis.…”
Section: Transcriptomic and Proteomic Analyzessupporting
confidence: 78%
“…Currently, the control of giardiasis depends mainly on the use of anti-Giardia drugs, such as metronidazole and tinidazole. However, frequent use of anti-Giardia drugs can lead to drug resistance and side effects (Krakovka et al, 2022). However, is no ideal vaccine, mainly because of a lack of understanding of the pathogenesis and regulatory mechanisms in Giardia infection.…”
Section: Giardiasis-giardiamentioning
confidence: 99%
“…The following PRIDE projects were used: PXD017597, PXD004398, PXD000452, PXD002398, PXD007183 and PXD022565. Additionally, two recent proteomic studies that used the update version of the Giardia genome were reanalyzed [77,78].…”
Section: Transcriptomic and Proteomic Analyses Among All Isolatesmentioning
confidence: 99%